Modulation of COX-2 Expression by Statins in Human Aortic Smooth Muscle Cells
Authors:
- Manlio BollaMBManlio Bolla
- Stéphanie BlaieSBStéphanie Blaie
- Christophe CréminonCCChristophe Créminon
- Isabelle QuéréIQIsabelle Quéré
- Patrice BoquetPBPatrice Boquet
- Sylviane Lévy-ToledanoSLSylviane Lévy-Toledano
- Jacques BertoglioJBJacques Bertoglio
- Aı̈da HabibAHAı̈da Habib
Open Access
- 1 December 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (50) , 46849-46855
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Atorvastatin Upregulates Type III Nitric Oxide Synthase in Thrombocytes, Decreases Platelet Activation, and Protects From Cerebral Ischemia in Normocholesterolemic MiceStroke, 2000
- Differential Regulation of COX-2 Transcription by Ras- and Rho-Family of GTPasesBiochemical and Biophysical Research Communications, 2000
- Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effectLife Sciences, 2000
- Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells.Journal of Clinical Investigation, 1998
- Inhibition of Protein Geranylgeranylation Causes a Superinduction of Nitric-oxide Synthase-2 by Interleukin-1β in Vascular Smooth Muscle CellsJournal of Biological Chemistry, 1997
- Immunological studies of human constitutive cyclooxygenase (COX-1) using enzyme immunometric assayBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Inhibition of Thromboxane Biosynthesis and Platelet Function by Simvastatin in Type IIa HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Regulation of the mevalonate pathwayNature, 1990
- Effects of a Competitive Inhibitor (Mevinolin) of 3‐Hydroxy‐3‐methylglutaryl Coenzyme A Reductase on Human and Bovine Endothelial Cells, Fibroblasts and Smooth Muscle Cells in VitroBasic & Clinical Pharmacology & Toxicology, 1989
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984